• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Kaleo Inc

Sanofi levels antitrust suit against Mylan over EpiPen device

April 24, 2017 By Sarah Faulkner

EpiPen

Sanofi (NYSE:SNY) reportedly sued Mylan (NSDQ:MYL) today, accusing the company of illegally suppressing competition to the EpiPen device. The lawsuit filed in a New Jersey federal court alleges that Mylan’s conduct has cost Sanofi hundreds of millions of dollars in sales for its rival allergy treatment, Auvi-Q. Canonsburg, Penn.-based Mylan has found itself at the center of […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Kaleo Inc, Merck, Mylan, Sanofi-Aventis

Grassley questions Auvi-Q’s list price, while Trump shows support for Medicare drug-pricing reform

March 10, 2017 By Sarah Faulkner

capitol hill

Although Mylan (NSDQ:MYL) has been under fire for its pricey EpiPen device since August last year, competitor Kaleo found itself garnering unwanted attention from politicians this week over the price of its epinephrine injection, Auvi-Q. Chairman of the Senate Judiciary Committee, Sen. Chuck Grassley (R-Iowa), wrote a letter to the Richmond, Virginia-based company asking CEO Spencer Williamson to explain […]

Filed Under: Auto-injectors, Featured, Pharmaceuticals, Policy, Wall Street Beat Tagged With: Kaleo Inc, Mylan

Demand for EpiPen alternatives jumps as states consider access legislation

March 7, 2017 By Sarah Faulkner

Mylan

Prescriptions for EpiPen alternatives such as Kaléo Inc.‘s Auvi-Q device have quadrupled since the beginning of this year, according to data from the Athenahealth Network. The demand for cheaper alternative devices is likely driven by revelations that Mylan (NSDQ:MYL) hiked the price of its EpiPen emergency allergy injector by 500% since it acquired the device in 2007. Generic […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Respiratory, Wall Street Beat Tagged With: Impax Laboratories, Kaleo Inc, Mylan, Teva Pharmaceuticals

Senators question Kaleo over pricey opioid overdose device

February 10, 2017 By Sarah Faulkner

Kaleo

In a letter signed by 30 U.S. senators, Sen. Claire McCaskill (D-Missouri) asked Kaleo Pharmaceutical to explain the 550% price hike for its Evzio opioid overdose device. The company’s product, which Kaleo sold for $690 in 2014, is priced at $4,500. Evzio is a naloxone auto-injector designed to reverse the effects of an opioid overdose. It can […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Capitol Hill, Kaleo Inc

Kaleo announces US availability, pricing of allergy auto-injector

January 20, 2017 By Sarah Faulkner

Kaleo announces US availability, pricing of allergy auto-injector

Kaléo Inc. said yesterday that its Auvi-Q epinephrine auto-injector will be available by prescription in the U.S. beginning Feb. 14th. The Richmond, Virginia-based company’s emergency allergy treatment was pulled from the market in 2015 due to manufacturing issues. The Epipen competitor device will be sold at a list price of $4,500, but Kaléo said that as a […]

Filed Under: Auto-injectors, Featured, Pharmaceuticals, Respiratory, Wall Street Beat Tagged With: Kaleo Inc, Mylan

Kaleo plans 2017 U.S. relaunch for EpiPen competitor Auvi-Q

October 26, 2016 By Sarah Faulkner

Kaleo

Kaléo Inc. said today that it plans to relaunch its Auvi-Q injector for emergency allergy treatment in the U.S. during the 1st half of 2017, according to Reuters.  The Richmond, Va.-based company’s device was recalled last year after concerns about the accuracy of delivered dose. Sanofi (NYSE:SNY) made and licensed the Auvi-Q device from Kaléo, but returned rights to […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured Tagged With: Kaleo Inc, Mylan, Sanofi-Aventis

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS